Lensar (LNSR) Total Current Liabilities (2019 - 2026)
Lensar's (LNSR) quarterly Total Current Liabilities came in at $17.8 million in Q1 2026, down 34.5% year-on-year from $27.2 million in Q1 2025, and down 56.13% on a QoQ basis from $40.6 million in Q4 2025.
Lensar (LNSR) Total Current Liabilities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Total Current Liabilities data on file, last reported at $17.8 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 34.5% year-over-year to $17.8 million in Q1 2026; TTM through Mar 2026 was $17.8 million, a 34.5% decrease from a year earlier, with the FY2025 full-year figure at $40.6 million, up 170.44% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $17.8 million, down from $40.6 million in the prior quarter.
- Over the last five years, Total Current Liabilities for LNSR reached as high as $40.6 million in Q4 2025 and fell as low as $7.8 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $16.6 million across 5 years, with a median of $11.4 million in 2022.
- Across the five-year window, Total Current Liabilities soared 205.92% in 2025 and slumped 34.5% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $11.4 million in 2022, then gained by 1.85% to $11.6 million in 2023, then grew by 28.98% to $15.0 million in 2024, then surged by 170.44% to $40.6 million in 2025, then plunged by 56.13% to $17.8 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $17.8 million in Q1 2026, $40.6 million in Q4 2025, and $35.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 17.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.80 Mn |
| Dec 31, 2025 | 40.57 Mn |
| Sep 30, 2025 | 35.73 Mn |
| Jun 30, 2025 | 30.09 Mn |
| Mar 31, 2025 | 27.17 Mn |
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 11.68 Mn |
| Jun 30, 2024 | 10.37 Mn |
| Mar 31, 2024 | 10.45 Mn |
| Dec 31, 2023 | 11.63 Mn |
| Sep 30, 2023 | 11.01 Mn |
| Jun 30, 2023 | 10.56 Mn |
| Mar 31, 2023 | 9.99 Mn |
| Dec 31, 2022 | 11.42 Mn |
| Sep 30, 2022 | 9.79 Mn |
| Jun 30, 2022 | 11.22 Mn |
| Mar 31, 2022 | 7.76 Mn |
| Dec 31, 2021 | 8.71 Mn |
| Sep 30, 2021 | 8.03 Mn |
| Jun 30, 2021 | 7.72 Mn |